45870 Federal Register / Vol. 82, No. 189 / Monday, October 2, 2017 / Notices 

MSC 7846, Bethesda, MD 20892, (301) 437– 

0911, kramerkm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Molecular 

Targets for Cancer Interventions. 

Date: October 26–27, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Guest Suites Santa 

Monica, 1707 Fourth Street, Santa Monica, 

CA 90401. 

Contact Person: Careen K Tang-Toth, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6214, 

MSC 7804, Bethesda, MD 20892, (301) 435– 

3504, tothct@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Urologic 

and Urogynecologic Applications. 

Date: October 26, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Washington National 

Airport, 1489 Jefferson Davis Hwy, Arlington, 

VA 22202. 

Contact Person: Ganesan Ramesh, Ph.D., 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 2182, MSC 7818, Bethesda, MD 20892, 

301–827–5467, ganesan.ramesh@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Sensory and Motor 

Neuroscience, Cognition and Perception. 

Date: October 26–27, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites by Hilton 

Alexandria Old Town, 1900 Diagonal Road, 

Alexandria, VA 22314. 

Contact Person: Sharon S Low, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5104, 

MSC 7846, Bethesda, MD 20892, 301–237– 

1487, lowss@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–17– 

047—Selective Cell and Network 

Vulnerability in Aging and Alzheimer’s 

Disease. 

Date: October 26, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin, Crystal City, 1800 

Jefferson Davis Highway, Arlington, VA 

22202. 

Contact Person: Afia Sultana, Ph.D., 

Scientific Review Officer, National Institutes 

of Health, Center for Scientific Review, 6701 

Rockledge Drive, Room 4189, Bethesda, MD 

20892, (301) 827–7083, sultanaa@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Somatosensory and Pain Systems. 

Date: October 26–27, 2017. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Darcy, 1515 Rhode Island 

Avenue NW., Washington, DC 20005. 

Contact Person: M Catherine Bennett, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1766, bennettc3@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–15– 

358—Molecular and Cellular Causal Aspects 

of Alzheimer’s Disease. 

Date: October 26, 2017. 

Time: 8:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin, Crystal City, 1800 

Jefferson Davis Highway, Arlington, VA 

22202. 

Contact Person: Afia Sultana, Ph.D., 

Scientific Review Officer, National Institutes 

of Health, Center for Scientific Review, 6701 

Rockledge Drive, Room 4189, Bethesda, MD 

20892, (301) 827–7083, sultanaa@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Learning, Memory, Synaptic 

Plasticity. 

Date: October 26, 2017. 

Time: 9:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Kirk Thompson, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5184, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1242, kgt@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Cardiovascular Disorders. 

Date: October 26, 2017. 

Time: 9:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Margaret Chandler, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4126, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1743, margaret.chandler@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Biomedical 

Imaging, Translational and Clinical Sciences 

Applications. 

Date: October 26, 2017. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Mehrdad Mohseni, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5211, 

MSC 7854, Bethesda, MD 20892, 301–435– 

0484, mohsenim@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 27, 2017. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–21134 Filed 9–29–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed Collection; 60-Day Comment 

Request; A Generic Submission for 

Formative Research, Pre-testing, 

Stakeholder (National Cancer Institute) 

AGENCY: National Institutes of Health, 

Department of Health and Human 

Services. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995 to provide 

opportunity for public comment on 

proposed data collection projects, the 

National Cancer Institute (NCI) will 

publish periodic summaries of propose 

projects to be submitted to the Office of 

Management and Budget (OMB) for 

review and approval. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 60 days of the date of this 

publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments, submit 

comments in writing, or request more 

information on the proposed project, 

contact: Amy Williams, Director of the 

Office of Advocacy Relations (OAR), 

NCI, NIH, 31 Center Drive, Bldg. 31, 

Room 10A28, MSC 2580, Bethesda, MD 

20892, call non-toll-free number 240– 

781–3406, or email your request, 

including your address, to 

amy.williams@nih.gov. Formal requests 

for additional plans and instruments 

must be requested in writing. 

SUPPLEMENTARY INFORMATION: Section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995 requires: written 

comments and/or suggestions from the 

public and affected agencies are invited 

to address one or more of the following 

points: (1) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

function of the agency, including 


sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 82, No. 189 / Monday, October 2, 2017 / Notices 45871 

whether the information will have 

practical utility; (2) The accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; (3) 

Ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Ways to minimize the 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Proposed Collection Title: A Generic 

Submission for Formative Research, Pretesting, Stakeholder Measures and 

Advocate Forms at NCI, 0925–0641. 

Extension. National Cancer Institute 

(NCI), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: This is a request for OMB to 

approve the extension of the generic 

collection titled, ‘‘A Generic Submission 

for Formative Research, Pre-testing, 

Stakeholder Measures and Advocate 

Forms at NCI’’ for an additional three 

years of data collection. The Office of 

Advocacy Relations (OAR) disseminates 

cancer-related information to a variety 

of stakeholders, seeks input and 

feedback, and facilitates collaboration to 

advance NCI’s authorized programs. It is 

beneficial for NCI, through the OAR, to 

pretest strategies, concepts, activities 

and materials while they are under 

development. Additionally, 

administrative forms are a necessary 

part of collecting demographic 

information and areas of interest for 

advocates. Since OAR is responsible for 

matching advocates to NCI programs 

and initiatives across the cancer 

continuum, it is necessary to measure 

the satisfaction of both internal and 

external stakeholders with this 

collaboration. This customer satisfaction 

research helps ensure the relevance, 

utility, and appropriateness of the many 

initiatives and products that OAR and 

NCI produce. The OAR will use a 

variety of qualitative (interviews) 

methodology to conduct this research, 

allowing NCI to: (1) Understand 

characteristics (attitudes, beliefs, and 

behaviors) of the intended target 

audience and use this information in the 

development of effective strategies, 

concepts, activities; (2) use a feedback 

loop to help refine, revise, and enhance 

OAR’s efforts—ensuring that they have 

the greatest relevance, utility, 

appropriateness, and impact for/to 

target audiences; and (3) expend limited 

program resource dollars wisely and 

effectively. The anticipated respondents 

will consist of: Adult cancer research 

advocates; members of the public; 

health care professionals; and 

organizational representatives. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

45. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average time 

per response 

(in hours) 

Total annual 

burden hour 

Individual In-Depth Interviews ......................................................................... 40 1 30/60 20 

Profile Completion ........................................................................................... 50 1 30/60 25 

Total .......................................................................................................... 90 90 ........................ 45 

Dated: September 19, 2017. 

Karla Bailey, 

Project Clearance Liaison, National Cancer 

Institute, National Institutes of Health. 

[FR Doc. 2017–21047 Filed 9–29–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Nursing Research; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Nursing Research Initial Review Group. 

Date: October 19–20, 2017. 

Time: 8:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Weiqun Li, MD, Scientific 

Review Officer, National Institute of Nursing 

Research National Institutes of Health, 6701 

Democracy Blvd., Suite 710, Bethesda, MD 

20892, (301) 594–5966, wli@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.361, Nursing Research, 

National Institutes of Health, HHS) 

Dated: September 26, 2017. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20992 Filed 9–29–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR17–122: 

NINDS Exploratory Clinical Trials. 

Date: October 20, 2017. 

Time: 10:00 a.m. to 1:00 p.m. 


sradovich on DSK3GMQ082PROD with NOTICES